F
Firebrick Pharma Ltd
ASX:FRE
Firebrick Pharma Ltd
ASX:FRE
Price:
0.058
AUD
7.41%
Market Cap:
AU$14.6m
Relative Value
The Relative Value of one FRE stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.058 AUD, Firebrick Pharma Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FRE Relative Value
HIDDEN
Multiples Across Competitors
FRE Competitors Multiples
Firebrick Pharma Ltd Competitors
Firebrick Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
F
|
Firebrick Pharma Ltd
ASX:FRE
|
14.6m AUD | 49.7 | -5.5 | -4.7 | -4.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.4B USD | 14.6 | 46.1 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.2B USD | 6.3 | 22.1 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.2B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.8B CHF | 5.6 | 22.5 | 13.9 | 17.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.4B GBP | 5.4 | 30.7 | 17 | 23.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.6 | 16.4 | 10.1 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.9 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.8B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
